Published

Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology
Date: 2025-07-01
Source: PubMed
DOI: 10.1038/s41386-025-02097-0
PubMed: 40205013

Authors

Bradley ER Sakai K Fernandes-Osterhold G Szigeti B Ludwig C Ostrem JL Tanner CM Bock MA Llerena K Finley PR O'Donovan A Zuzuarregui JRP Busby Z McKernan A Penn AD Wang ACC Rosen RC Woolley JD

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Safety Adverse Events Other

Citation graph

0 referenced DOIs found in stored source metadata. 4 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview2026-07-13 Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis2026-05-29 Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headache2026-05-29 Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.2025-07-01

Related papers

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-08-07 The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.ClinicalTrials.gov · 2026-05-08 Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot StudyClinicalTrials.gov · 2025-01-01 Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-report.Journal of Parkinson's disease · 2025-03-01 The Efficacy of Psilocybin Therapy for Depression in Parkinson's DiseaseClinicalTrials.gov · 2026-08-07 Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity.Neuropsychiatric disease and treatment · 2025-01-01 Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.Neuropsychiatric disease and treatment · 2024-01-01 Hallucinogenic mushroom misuse reported to Texas poison centers.Journal of addictive diseases · 2020-01-01